OrganoClick takes $1.3M Almi loan to fund its turnaround
What's the deal? OrganoClickDealroom has a profile for this one. Try Dealroom →, a Swedish green chemicals company, has secured a US$1.57M loan from state-backed lender AlmiDealroom has a profile for this one. Try Dealroom →. The debt carries a 60-month term with straight-line amortization after an initial six-month grace period.
What's the endgame? OrganoClick replaces hidden plastic and harmful chemicals in fibre-based materials with fossil-free alternatives, from biobased binders for paper to the OrganoTex textile treatment and OrganoWoodDealroom has a profile for this one. Try Dealroom → wood protection. It says the loan gives it room to expand its consumer brands internationally as several industrial customer projects near commercialization.
Why now? The company is in the middle of a turnaround. Third-quarter sales fell 50% year on year to US$1.35M after the loss of a major industrial customer, though its operating loss narrowed as it cut costs.
What's the CEO saying? "Now we continue to focus on our sales development, adapting our cost structure according to our plan, and make the strategic change of business model within our business unit Wood protection," said chief executive officer Mårten Hellberg.
The loan follows a roughly US$3.99M rights issue earlier in 2026, which the company used mainly to repay debt. It is now shifting its wood-protection business toward a licensing model.
What could go wrong? The Almi loan adds liquidity, but it is debt, not fresh equity. That makes delivery on sales growth and the commercialization of industrial projects crucial to servicing it.
The signal: For a small Nasdaq First North-listed company under pressure, state-backed debt offers runway without further diluting shareholders. The money buys time; the strategy still has to prove it can reverse the sales decline.
Read more: view.news.eu.nasdaq.com
Image credit: Generated with Gemini
